{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:45:27Z","timestamp":1780458327232,"version":"3.54.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The purpose of the current study was to compare the diagnostic performances of radiolabeled FAPI and <jats:sup>18<\/jats:sup>F-FDG PET\/CT for the detection of lymph node (LN) metastasis in head and neck cancer (HNC) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The PubMed, Cochrane database, and EMBASE database, from the earliest available date of indexing through December 31, 2024, were searched for studies comparing diagnostic performances of radiolabeled FAPI and <jats:sup>18<\/jats:sup>F-FDG PET\/CT for the detection of metastatic LN in HNC patients. We estimated pooled sensitivities and specificities across studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Across 8 studies (14 results), the pooled sensitivity of FAPI PET\/CT was 0.89 and the pooled specificity was 0.93. The pooled sensitivity of <jats:sup>18<\/jats:sup>F-FDG PET\/CT was 0.91 and the pooled specificity was 0.50. On patient-based analysis, the estimated sensitivity and specificity of FAPI were 0.96 and 0.96, and those of <jats:sup>18<\/jats:sup>F-FDG were 0.95 and 0.34, respectively. On lesion-based analysis, the estimated sensitivity and specificity of FAPI were 0.84 and 0.94, and those of <jats:sup>18<\/jats:sup>F-FDG were 0.86 and 0.78, respectively. On neck side\u2013based analysis, the estimated sensitivity and specificity of FAPI were 0.88 and 0.79, and those of <jats:sup>18<\/jats:sup>F-FDG were 0.91 and 0.29, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Radiolabeled FAPI showed a good diagnostic performance for the detection of metastatic LN in HNC patients. Also, <jats:sup>18<\/jats:sup>F-FDG PET\/CT revealed low specificity for LN staging in HNC patients. Future large multicenter research with more patients would be necessary to provide a more comprehensive overview of the usefulness of radiolabeled FAPI for LN staging in HNC patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005973","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:09:54Z","timestamp":1747242594000},"page":"840-846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Performances of Radiolabeled FAPI PET\/CT for Lymph Node Staging in Head and Neck Cancer Patients: Comparison With 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"given":"Yun Seong","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine"},{"name":"BioMedical Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Jang","family":"Kim","sequence":"additional","affiliation":[{"name":"BioMedical Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital"},{"name":"Department of Nuclear Medicine, Pusan National University School of Medicine"},{"name":"Department of Nuclear Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250731","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B","article-title":"Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma","volume":"71","author":"Leemans","year":"1993","journal-title":"Cancer"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s003300101102","article-title":"Imaging of lymphadenopathy in the neck","volume":"12","author":"Castelijns","year":"2002","journal-title":"Eur Radiol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2422051113","article-title":"PET\/CT: form and function","volume":"242","author":"Blodgett","year":"2007","journal-title":"Radiology"},{"key":"R6-20250731","first-page":"1200","article-title":"Clinical performance of PET\/CT in evaluation of cancer: additional value for diagnostic imaging and patient management","volume":"44","author":"Bar-Shalom","year":"2003","journal-title":"J Nucl Med"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00000658-200002000-00012","article-title":"Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography","volume":"231","author":"Stokkel","year":"2000","journal-title":"Ann Surg"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12149-007-0097-9","article-title":"Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer","volume":"22","author":"Yamazaki","year":"2008","journal-title":"Ann Nucl Med"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/ijms20071723","article-title":"The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma","volume":"20","author":"Baglieri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol Rev"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","article-title":"Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET\/CT versus MRI and [18F]-FDG PET\/CT","volume":"48","author":"Guo","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","article-title":"The role of 68Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience","volume":"61","author":"Koerber","year":"2020","journal-title":"J Nucl Med"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume":"309","author":"Thompson","year":"1994","journal-title":"BMJ"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jclinepi.2007.03.016","article-title":"The binomial distribution of meta-analysis was preferred to model within-study variability","volume":"61","author":"Hamza","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat Med"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer","year":"1999","journal-title":"JAMA"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1007\/s00330-022-08686-7","article-title":"Accurate preoperative staging with [68Ga]Ga-FAPI PET\/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET\/CT","volume":"32","author":"Chen","year":"2022","journal-title":"Eur Radiol"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"1047010","DOI":"10.3389\/fonc.2022.1047010","article-title":"Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET\/CT for tumor staging in nasopharyngeal carcinoma","volume":"12","author":"Ding","year":"2022","journal-title":"Front Oncol"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40644-024-00699-3","article-title":"Head-to-head comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET\/CT for the evaluation of tonsil cancer and lymph node metastases: a single-centre retrospective study","volume":"24","author":"Ji","year":"2024","journal-title":"Cancer Imaging"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s00259-023-06138-y","article-title":"The performance of 68Ga-FAPI-04 PET\/CT in head and neck squamous cell carcinoma: a prospective comparison with 18F-FDG PET\/CT","volume":"50","author":"Jiang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R30-20250731","first-page":"122","article-title":"[68Ga]Ga-FAPI04 outperforms [18F]FDG PET\/CT for detecting nodal metastasis of head and neck squamous cell carcinoma: a single-center experience","volume":"40","author":"Kuyumcu","year":"2025","journal-title":"Cancer Biother Radiopharm"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00259-021-05422-z","article-title":"Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity\u2014initial experience and comparison to [18F]FDG PET\/CT and MRI","volume":"48","author":"Linz","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1007\/s00259-021-05255-w","article-title":"A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET\/MR in patients with nasopharyngeal carcinoma: a prospective study","volume":"48","author":"Qin","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s00259-021-05336-w","article-title":"Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography\/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma","volume":"48","author":"Zhao","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00330-008-1192-6","article-title":"CT, MR, US, 18F-FDG PET\/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck","volume":"19","author":"Yoon","year":"2009","journal-title":"Eur Radiol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/snuc.2001.26189","article-title":"Radiopharmaceuticals to image infection and inflammation","volume":"31","author":"Boerman","year":"2001","journal-title":"Semin Nucl Med"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/snuc.2002.29278","article-title":"18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation","volume":"32","author":"Zhuang","year":"2002","journal-title":"Semin Nucl Med"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/RLU.0b013e318212c872","article-title":"Atlas of confounding factors in head and neck PET\/CT imaging","volume":"36","author":"Bhargava","year":"2011","journal-title":"Clin Nucl Med"},{"key":"R38-20250731","author":"Pfister"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.7150\/jca.25775","article-title":"The expression of FAP in hepatocellular carcinoma cells is induced by hypoxia and correlates with poor clinical outcomes","volume":"9","author":"Zou","year":"2018","journal-title":"J Cancer"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","article-title":"Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers","volume":"91","author":"Scanlan","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R41-20250731","doi-asserted-by":"crossref","first-page":"140409","DOI":"10.1016\/j.bbapap.2020.140409","article-title":"Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications","volume":"1868","author":"\u0160imkov\u00e1","year":"2020","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2214\/AJR.20.24302","article-title":"Will FAPI PET\/CT replace FDG PET\/CT in the next decade? Point-an important diagnostic, phenotypic, and biomarker role","volume":"216","author":"Calais","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2214\/AJR.22.28402","article-title":"Head-to-head comparison of 68Ga-FAPI PET\/CT and FDG PET\/CT for the detection of peritoneal metastases: systematic review and meta-analysis","volume":"220","author":"Gege","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"111302","DOI":"10.1016\/j.ejrad.2024.111302","article-title":"Head-to-head comparison of [68Ga]Ga-FAPI PET and [18F]FDG PET in the detection of bone and lymph node metastasis in various cancers: a systematic review and meta-analysis","volume":"171","author":"Wu","year":"2024","journal-title":"Eur J Radiol"},{"key":"R45-20250731","first-page":"35","article-title":"Head to head comparison of 68Ga-FAPI PET\/CT with 18F-FDG PET\/CT in primary and metastatic lesions of gastric tumor: a systematic review and meta-analysis","volume":"27","author":"Gao","year":"2024","journal-title":"Hell J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:23Z","timestamp":1753938023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005973","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"2025-02-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}